Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Mexico
  4. Mexican Stock Exchange
  5. Genomma Lab Internacional, S.A.B. de C.V.
  6. Company
    LAB B   MX01LA010006

GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.

(LAB B)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Genomma Lab Internacional SAB de CV is a Mexico-based over-the-counter pharmaceutical (OTC pharmaceutical), generic drugs (GD) and personal care products company. The Company is engaged in the development, distribution and marketing of a range of products within different brands, for such treatments as anti-acne, varicose vein, hair loss, sexual stimulation and influenza; as well as analgesics and antifungals. The Company’s product portfolio includes such brands as Asepxia, Cicatricure, Goicoechea, Bengue, Diabet TX, Genoprazol, Goicotabs, Shot B, SilkaMedic, Siluet 40, Nikzon, X Ray, Next, Touch Me, Lomecan V and QG5, among others. The Company is a parent of a number of controlled entities, which have operations established in Mexico, the United States, Peru, Chile, Ecuador and Honduras, among others. In June 2014, the Company acquired 50% stake in Grupo Comercial e Industrial Marzam SA de CV.

Number of employees : 1 161 people.
Sales per Business
20192020Delta
Free-selling Pharmaceutical Products and Personal Care Products12 712.90100%13 870.10100% +9.1%
MXN in Million
Sales per region
20192020Delta
International6 910.0754.4%7 866.0256.7% +13.83%
Mexico5 802.8245.6%6 004.1343.3% +3.47%
MXN in Million
Managers
Name Title Age Since
Jorge Luis Brake Valderrama Chief Executive Officer - 2018
Antonio Zamora Galland Vice President-Administration & Finance - -
Marco Sparvieri Chief Operating Officer & Executive Vice President - -
Juan Alonso Independent Director - -
Juan Carlos Gavito Aspe Independent Director - -
Jorge Ricardo Gutiérrez Muñoz Independent Director 76 -
Javier Vale Castilla Independent Director - -
Ignacio Gonzalez Rodriguez Independent Director - -
Burkhard Wittek, Dr. Independent Director 68 2018
Carlos Javier Vara Alonso Independent Director - 2018
Members of the board
Name Title Age Since
Rodrigo Alonso Herrera Aspra Chairman - -
Juan Alonso Independent Director - -
Sabrina Lucila Herrera Aspra Director - -
Juan Carlos Gavito Aspe Independent Director - -
Jorge Ricardo Gutiérrez Muñoz Independent Director 76 -
Javier Vale Castilla Independent Director - -
Ignacio Gonzalez Rodriguez Independent Director - -
Burkhard Wittek, Dr. Independent Director 68 2018
Carlos Javier Vara Alonso Independent Director - 2018
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,048,000,000 743,241,600 70.9% 39,864,578 3.8% 70.9%
Shareholders
NameEquities%
Rodrigo Alonso Herrera Aspra 295,536,000 28.2%
Massachusetts Financial Services Co. 50,176,820 4.79%
Norges Bank Investment Management 49,634,114 4.74%
Fidelity Management & Research Co. LLC 49,425,267 4.72%
Capital Research & Management Co. (World Investors) 35,953,000 3.43%
AllianceBernstein LP 27,284,623 2.60%
The Vanguard Group, Inc. 24,383,095 2.33%
Invesco Advisers, Inc. 19,864,131 1.90%
BlackRock Fund Advisors 16,355,037 1.56%
BlackRock México SA de CV Asesor en Inversiones Independiente 14,405,512 1.37%
Company contact information
Genomma Lab Internacional SAB de CV
Avendia Antonio Dovalí Jaime, 70
Torre C, Piso 2, Despacho A
Col. Santa Fe, Del. Álvaro Obregnó
Mexico City, Distrito Federal 01210

Phone : +52.55.5081.0000
Fax : +52.55.5081.0000
Web : http://www.genommalab.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Genomma Lab Internacional, S.A.B. de C.V.
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.10.67%1 051
JOHNSON & JOHNSON4.68%433 701
ROCHE HOLDING AG10.97%321 442
PFIZER, INC.20.81%246 078
NOVO NORDISK A/S50.80%232 556
ELI LILLY AND COMPANY36.28%208 604
ABBVIE INC.0.54%190 378
NOVARTIS AG-7.42%186 081
MERCK & CO., INC.-12.37%181 449
ASTRAZENECA PLC10.09%171 794
BRISTOL-MYERS SQUIBB COMPANY-1.16%136 238
AMGEN INC.-4.58%124 575
SANOFI3.62%120 158
GLAXOSMITHKLINE PLC3.44%95 560
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-23.73%62 799
TAKEDA PHARMACEUTICAL COMPANY LIMITED1.54%54 566
BAYER AG-6.12%52 137
DAIICHI SANKYO COMPANY, LIMITED-20.66%48 910
JIANGSU HENGRUI MEDICINE CO., LTD.-49.45%46 272
ASTELLAS PHARMA INC.18.51%31 855